We're proud to receive a 2025 CDMO Leadership Award in the “Small Molecule Dosage Form - Global" category.
Over the last decade, Patheon pharma services has supported the delivery of more NDA-approved drugs than the next three leading CMOs combined. What’s more, we’ve delivered across all phases of drug development and across the world through our full-service global network.
Find out how we help our clients on their journey to NDA approval.